We are live on
!
Find out more
NERM
New England Research & Management Portfolio holdings
AUM
$257M
1-Year Est. Return
25.66%
This Fund
S&P 500
This Quarter
Est. Return
+0.71%
1 Year Est. Return
+25.66%
3 Year Est. Return
+56.38%
5 Year Est. Return
+58.71%
10 Year Est. Return
+176.32%
AUM
$118M
AUM Growth
+$1.99M
(+1.7%)
Cap. Flow
+$889K
Cap. Flow
% of AUM
0.76%
Top 10 Holdings %
Top 10 Hldgs %
23.3%
Holding
183
New
19
Increased
63
Reduced
50
Closed
24
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kimberly-Clark
KMB
|
+$1.05M |
| 2 |
Valero Energy
VLO
|
+$668K |
| 3 |
FLTX
Fleetmatics Group PLC
FLTX
|
+$646K |
| 4 |
L3Harris
LHX
|
+$628K |
| 5 |
PRXL
Parexel International Corp
PRXL
|
+$626K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$1.06M |
| 2 |
Seagate
STX
|
+$770K |
| 3 |
Gen Digital
GEN
|
+$759K |
| 4 |
Brinker International
EAT
|
+$751K |
| 5 |
Amgen
AMGN
|
+$661K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 18.44% |
| 2 | Healthcare | 17.12% |
| 3 | Consumer Staples | 15.75% |
| 4 | Financials | 14.88% |
| 5 | Consumer Discretionary | 12.53% |
Similar funds
GCCM
EBWM
HFRG
ACM
CCA
PHAM
TC
New England Research & Management's Q1 2016 Portfolio in Review
As of Q1 2016, New England Research & Management held 183 positions worth $118M, up 1.7% from $116M the previous quarter. Its ten largest holdings account for 23% of the portfolio.
New England Research & Management's Q1 2016 filing shows 19 new, 63 increased, 50 reduced and 24 closed positions. Its largest new stake was Valero Energy: 10,500 shares worth $673K. The largest sale was Medtronic, an estimated $1.06M.
By sector, the portfolio is most concentrated in Industrials at 18% of assets, up from 18% a quarter earlier, followed by Healthcare and Consumer Staples.
- New England Research & Management's largest Q1 2016 buy was Valero Energy: 10,500 shares worth $673K.
- New England Research & Management added most to Kimberly-Clark in Q1 2016, an estimated $1.05M increase.
- New England Research & Management's biggest Q1 2016 reduction was Amgen, cutting an estimated $661K.
- New England Research & Management fully exited Medtronic in Q1 2016, selling an estimated $1.06M.
- New England Research & Management's ten largest holdings make up 23% of its $118M portfolio in Q1 2016.
- New England Research & Management opened 19 new positions and closed 24 in Q1 2016.
- New England Research & Management's portfolio value rose 1.7% quarter-over-quarter to $118M.
Based on New England Research & Management's 13F filing for Q1 2016, filed 6 Apr 2016.